Disruptive Technologies & Game-changing Companies in the Global Pharmaceutical Cell Banking Market - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Disruptive Technologies and Game-changing Companies in the Global Pharmaceutical Cell Banking Market" report to their offering.

This market insight on the global cell banking market analyses disruptive technologies and provides details on game-changing companies. Biopharmaceutical companies are increasingly partnering with CMOs and CROs to store their proprietary cell lines and develop new ones. With increased collaborations, CMOs are coming up with niche and specific services for cell line development and cell banking.

They are focusing on providing gene to GMP services, thereby expanding their service portfolios. Mammalian cell culture technology is the highest-growing system across all other cell systems. With the increase in infectious diseases, the development of novel mammalian cell culture systems is expected to evolve. With the growing need for the proper storage of cultured cell banks, CMOs are developing long-term preservation techniques through continuous temperature monitoring.

With the emergence of single-use technologies and new developments in cryopreservation technologies and upstream/downstream processes, the cell banking market is expected to experience robust growth, with the major share being captured by contractors as they specialise in new technologies. CMOs are turning towards emerging markets such as Asia-Pacific. However, issues with delivery, service, IP protection, and regulatory and product quality are curbing growth.

Companies Mentioned

  • BioReliance Corporation
  • Charles River Laboratories
  • Eurofins
  • Lonza
  • SGS Life Sciences
  • Wuxi AppTech

Key Topics Covered:

1. Executive Summary

2. Market Overview

3. Technology Process Overview

4. Key Technology Trends

5. Key Technologies

6. Key Technology Platforms

7. Key Companies to Action

8. Key Mergers and Acquisitions and Partnerships and Collaborations

9. Growth Opportunities

10. The Last Word

For more information about this report visit http://www.researchandmarkets.com/research/4n9jc5/disruptive

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Pharmaceuticals, Computing, Stem Cells

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Pharmaceuticals, Computing, Stem Cells